project id: TCGA-ESCA; case submitter id: TCGA-XP-A8T8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.73; rna integrity number: 7.4; age at index: 49; days to birth: -18048; ethnicity: hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1962; age at diagnosis: 18048; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IIB; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 437.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 1.0410958904109588; pack years smoked: 19.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 930; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-XP-A8T8-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;